Sacituzumab Tirumotecan in EGFR-TKI–Resistant, <i>EGFR</i> -Mutated Advanced NSCLC

Wenfeng Fang

Department of Medical Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Provincial Clinical Research Center for Cancer, Guangzhou, China

Lin Wu

The Department of Thoracic Medical Oncology Hunan Cancer Hospital/The Affiliated Cancer Hospital of Xiangya School of Medicine Central South University Changsha China

Xiangjiao Meng

Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, China

Yu Yao

Key Laboratory for Advanced Materials and Joint International Research Laboratory of Precision Chemistry and Molecular Engineering, Feringa Nobel Prize Scientist Joint Research Center, Frontiers Science Center for Materiobiology and Dynamic Chemistry, Institute of Fine Chemicals, School of Chemistry and Molecular Engineering

Wei Zuo

Department of Respiratory Medicine, First Affiliated Hospital of Nanchang University, Nanchang, China

Wenxiu Yao

Department of Medical Oncology, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital and Institute, Sichuan Cancer Center, University of Electronic Science and Technology of China, Chengdu, China

Yanyan Xie

Department of Breast Surgical Oncology, People’s Hospital of Guangxi Zhuang Autonomous Region, Nanning, China

Yu Zhang

Xiangya Hospital, Central South University Changsha China

Jiuwei Cui

Yongchang Zhang

Xingya Li

Department of Medical Oncology, First Affiliated Hospital of Zhengzhou University, Zhengzhou, China

Wu Zhuang

Department of Thoracic Oncology, Fujian Cancer Hospital, Fuzhou, China

Jian Fang

Qiming Wang

Department of Internal Medicine, Affiliated Cancer Hospital of Zhengzhou University and Henan Cancer Hospital, Institute of Cancer Research, Henan Academy of Innovations in Medical Science, Zhengzhou, China

Wei Jiang

Kai Li

Yuju Bai

Department of Thoracic Oncology, Second Affiliated Hospital of Zunyi Medical University, Zunyi, China

Yongzhong Luo

Thoracic Medicine Department I, Hunan Cancer Hospital/Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, China

Fang Ma

Yan Yu

Department of Respiratory Oncology Harbin Medical University Cancer Hospital Harbin China

Wei Zheng

Zhentian Liu

Department of Thoracic Oncology, Jiangxi Cancer Hospital, Nanchang, China

Bin Yang

Rui Ma

College of Materials, State Key Laboratory of Physical Chemistry of Solid Surfaces, iChEM, College of Chemistry and Chemical Engineering, College of Energy, School of Life Sciences, College of Physical Science and Technology, and Discipline of Intelligent Instrument and Equipment

Yong Fang

Runxiang Yang

Department of Internal Medicine I, Third Affiliated Hospital of Kunming Medical University, Yunnan Cancer Hospital, Kunming, China

Liyan Jiang

Department of Respiratory Medicine, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai

Jie Hu

School of Biomedical Sciences and Engineering

Jiacheng Yang

Clinical Research Center, Sichuan Kelun-Biotech Biopharmaceutical, Chengdu, China

Yina Diao

Clinical Research Center, Sichuan Kelun-Biotech Biopharmaceutical, Chengdu, China

Xiaoping Jin

Clinical Research Center, Sichuan Kelun-Biotech Biopharmaceutical, Chengdu, China

Junyou Ge

National Engineering Research Center of Targeted Biologics, Chengdu, China

Yunpeng Yang

Department of Medical Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Provincial Clinical Research Center for Cancer, Guangzhou, China

Li Zhang